Browsing Category

Top Industry News

7526 posts

Bristol Myers Squibb, Bain Capital Form New Immunology Company
By

By
Bristol Myers Squibb (BMS) and Bain Capital have announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new therapies for autoimmune diseases. The newly formed company…

Evotec, Sandoz in Potential Sale of Evotec’s EU Continuous Biomanufacturing Unit
By

By
Evotec and Sandoz have signed a non-binding term sheet on the planned sale of Just–Evotec Biologics EU,  Evotec’s continuous biomanufacturing unit in Toulouse, France, to Sandoz for approximately $300 million.  …

Simtra BioPharma Solutions Plans US Injectables Mfg Expansion
By

By
Simtra BioPharma Solutions, a CDMO specializing in injectable medicines, reports that it has purchased a 65-acre property in Bloomington, Indiana, with more than 300,000 square feet of available space for…

President Trump Sends Letters To Pharma Companies To Advance Most-Favored-Nation Drug Pricing
By

By
This week (July 31, 2025), President Donald J. Trump sent letters to leading pharmaceutical manufacturers outlining the steps they must take to be in alignment with most-favored-nation drug pricing. The…

AstraZeneca to Invest $50 Bn in US by 2030 
By

By
AstraZeneca has announced plans to invest $50 billion in the US by 2030.   The main investment is a new multi-billion dollar US manufacturing facility that will produce drug substances for…

Biogen to Invest $2 Bn in Mfg Expansion 
By

By
Biogen has announced plans to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Biogen has invested approximately $10 billion in its…

FDA Names New Head of CDER   
By

By
The US Food and Drug Administration (FDA) has announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER).  Dr. Tidmarsh…

Sanofi Completes $9.5-Bn Acquisition of Blueprint Medicines 
By

By
Sanofi has completed its acquisition of Blueprint Medicines, a Cambridge, Massachusetts-based bio/pharmaceutical company specializing in rare diseases, in a $9.5-billion deal ($9.1 billion upfront and up to $400 million in…

Supplier News: Solvias, Sanner, Stevanato & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Solvias, Sanner, Stevanato Group, Abzena, Coriolis Pharma and Roquette.   Biologics Manufacturing * Solvias Opens Center of Excellence for Biologics & New Modalities Formulation Development/Drug…

Global Briefs: Moderna, Sarepta, Sanofi & More 
By

By
A roundup of news from Moderna, Sarepta Therapeutics, Sanofi, UK Government, GenesisM and Johnson & Johnson/Pacira Biosciences. Highlights below.   Mfg News * Moderna Nixes Plan for mRNA Mfg Plant in Japan *…